Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 2 Antimicrobial resistance profiles of isolated Salmonella serovars

From: Antimicrobial resistance profiles and virulence genotyping of Salmonella enterica serovars recovered from broiler chickens and chicken carcasses in Egypt

Serovars (n) Antimicrobial resistance
SXT AMP AMC S DO CEC C FEP CTX CIP IPM
S. Enteritidis (48) 48 34 42 28 24 20 12 10 6 6 0
S. Typhimurium (36) 36 18 22 22 14 18 6 4 4 2 0
S. Kentucky (12) 12 12 10 10 8 4 2 2 6 4 0
S. Molade (12) 12 8 6 8 2 2 0 0 0 0 0
S. Bargny (6) 6 4 2 4 0 0 0 0 0 0 0
S. Inganda (4) 4 4 0 4 0 0 0 0 0 0 0
S. Infantis (2) 2 2 0 2 0 0 0 0 0 0 0
Total (120) 120 82 82 78 48 44 20 16 16 12 0
a Resistant % 100% 68.% 68.% 65% 40% 36.7% 16.7% 13.3% 13.3% 10% 0
a Intermediate % 0 4.2% 0 8.3% 10.8% 12.5% 16.7% 0 5.8% 0 0
a Susceptible % 0 27.5% 36.7% 26.7% 49.2% 50.8% 66.7% 86.7% 80.8% 90% 100%
  1. AMC Amoxicillin-clavulanic acid, AMP Ampicillin, CEC Cefaclor, CTX Cefotaxime, FEP Cefepime, DO Doxycycline, CIP Ciprofloxacin, IPM Imipenem, S Streptomycin, C Chloramphenicol and SXT Trimethoprim sulfamethoxazole
  2. aThe percentage of the total number of isolates resistant, intermediate, or susceptible for a particular antimicrobial is indicated in the last three rows below each antimicrobial